Novartis (NVSN) Q2 2018 Earnings Report
MX:NVSN Q2 2018 EPS Results
- Actual EPS
- MXN 21.30
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 20.14
MX:NVSN Q2 2018 Revenue Results
- Actual Revenue
- MXN 245.84B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 07/18/2018
- Time
- TBA
- Conference Call
- Wednesday, July 18, 2018
MX:NVSN Upcoming Earnings
Novartis's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVSN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 41.80- | 37.93 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 42.4345.96 | 42.04 | 9.33% (+3.92) | |
| Jul 21, 2026 | 2026 (Q2) | 40.5845.03 | 45.21 | -0.41% (-0.19) | |
| Apr 28, 2026 | 2026 (Q1) | 39.2037.18 | 42.6 | -12.72% (-5.42) | |
| Feb 04, 2026 | 2025 (Q4) | 37.0537.93 | 36.99 | 2.53% (+0.93) | |
| Oct 28, 2025 | 2025 (Q3) | 42.4742.04 | 38.49 | 9.22% (+3.55) | |
| Jul 17, 2025 | 2025 (Q2) | 43.9345.21 | 36.81 | 22.84% (+8.41) | |
| Apr 29, 2025 | 2025 (Q1) | 39.5042.60 | 33.63 | 26.67% (+8.97) | |
| Jan 31, 2025 | 2024 (Q4) | 33.7236.99 | 28.59 | 29.41% (+8.41) | |
| Oct 29, 2024 | 2024 (Q3) | 36.2138.49 | 32.51 | 18.39% (+5.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
